Antiprogestin-Mediated Inactivation of Cytochrome P450 3A4
- 18 February 1998
- journal article
- research article
- Published by S. Karger AG in Pharmacology
- Vol. 56 (3) , 150-157
- https://doi.org/10.1159/000028193
Abstract
Based on previous observations of very short periods of linearity for antiprogestin metabolite formation and the presence of a common tertiary amine moiety in each compound as the principal site of their metabolism, we hypothesized that mifepristone, lilopristone and onapristone are oxidized by cytochrome P450 (CYP) 3A4 to reactive nitroso species that complex the heme of the enzyme, thereby inactivating it. Upon preincubation with human liver microsomes in the presence (but not the absence) of NADPH, mifepristone inhibited midazolam 1′-hydroxylation, a marker of CYP3A4 catalytic activity, very potently (IC50 ∼3.5 µmol/l) and extensively (by ∼87%). Lilopristone and onapristone also displayed NADPH and time-dependent inactivation of CYP3A4 with characteristics very similar to mifepristone. These data support antiprogestin-mediated inactivation of CYP3A4 and suggest the potential for drug-drug interactions and time-dependent nonlinearities in pharmacokinetics upon their long-term administration.Keywords
This publication has 9 references indexed in Scilit:
- Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation: Metabolic drug interactionsBiochemical Pharmacology, 1993
- Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomesBiochemical Pharmacology, 1991
- Treatment of breast cancer with different antiprogestins: Preclinical and clinical studiesThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Pharmacokinetics and metabolism of RU 486Journal of Steroid Biochemistry, 1987
- Hypo activity of cytochrome P-450 after triacetyloleandomycin administrationBiochemical Pharmacology, 1981
- Self-induction by triacetyloleandomycin of its own transformation into a metabolite forming a stable 456 nm-absorbing complex with cytochrome P-450Biochemical Pharmacology, 1981
- Published by Elsevier ,1979
- A new class of inhibitory cytochrome P-450 complexes formed during metabolism: A comparison with amphetamine and SKF 525-A type complexesChemico-Biological Interactions, 1976
- Diethylaminoethyl 2,2-diphenylvalerate HCl (SKF 525-A)—In vivo and in vitro effects of metabolism by rat liver microsomes—Formation of an oxygenated complexBiochemical Pharmacology, 1972